Home › NDC Lookup › RxCUI directory › RxCUI 1375917

Bromfenac 0.7 MG/ML Ophthalmic Solution — RxCUI 1375917

RxNorm drug concept · Semantic clinical drug
RxCUI 1375917 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1375917
Official nameBromfenac 0.7 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbromfenac 0.07 % Ophthalmic Solution; bromfenac 0.7 MG/ML (as bromfenac sodium 0.805 MG/ML) Ophthalmic Solution
FDA products mapped8
Package NDCs mapped11
Reported Medicaid activity (SDUD)2,510 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bromfenac Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Bromfenac eye drops are used specifically around the time of cataract surgery. They help reduce inflammation — the swelling and irritation inside your eye — and ease eye pain durin...
  • Tilt your head back, pull down your lower eyelid gently, and place one drop into the affected eye once a day. The most important things to remember: don't let the dropper tip touch...
  • How do I use the drops correctly without causing problems?
  • No — take your contact lenses out before you put the drops in. The preservative in bromfenac eye drops can be absorbed by soft contact lenses, which isn't good for your eyes or you...
📖 Read our full Bromfenac Ophthalmic guide →

🕸️ Concept Web — How Bromfenac 0.7 MG/ML Ophthalmic Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bromfenac 0.7 MG/ML Ophthalmic Solution RxCUI 1375917

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bromfenac 19737
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prolensa 1375918
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bromfenac Ophthalmic Solution 578017
    • Bromfenac Ophthalmic Product 1163102
    • Bromfenac Ophthalmic Solution [Prolensa] 1375920
    • Prolensa Ophthalmic Product 1375921
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bromfenac 0.7 MG/ML SCDC · 1375916
  • Bromfenac Ophthalmic Solution SCDF · 578017
  • Bromfenac Ophthalmic Product SCDG · 1163102

Brand-Name Concepts

📦 FDA Products & Package NDCs

8 products · 11 package NDCs
11 package NDCs map to RxCUI 1375917 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0602-03 1 BOTTLE, DROPPER in 1 CARTON (24208-602-03) / 3 mL in 1 BO... Prolensa Bausch & Lomb Incorporated 2013-04-05
24208-0602-04 1 BOTTLE, DROPPER in 1 CARTON (24208-602-04) / 3 mL in 1 BO... Prolensa Bausch & Lomb Incorporated 2013-04-05
24208-0602-06 1 BOTTLE, DROPPER in 1 CARTON (24208-602-06) / .6 mL in 1 B... Prolensa Bausch & Lomb Incorporated 2013-04-05
46708-0583-03 1 BOTTLE in 1 CARTON (46708-583-03) / 3 mL in 1 BOTTLE BROMFENAC SODIUM Alembic Pharmaceuticals Limited 2024-07-08
60219-1526-03 1 BOTTLE, DROPPER in 1 CARTON (60219-1526-3) / 3 mL in 1 BO... Bromfenac Amneal Pharmaceuticals NY LLC 2024-07-31
60505-1006-01 1 BOTTLE, DROPPER in 1 CARTON (60505-1006-1) / 1.6 mL in 1... Bromfenac Ophthalmic Solution, 0.07% Apotex Corp. 2024-07-11
60505-1006-02 1 BOTTLE, DROPPER in 1 CARTON (60505-1006-2) / 3 mL in 1 BO... Bromfenac Ophthalmic Solution, 0.07% Apotex Corp. 2024-07-11
62332-0583-03 1 BOTTLE in 1 CARTON (62332-583-03) / 3 mL in 1 BOTTLE BROMFENAC SODIUM Alembic Pharmaceuticals Inc. 2024-07-08
68180-0433-02 1 BOTTLE, DROPPER in 1 CARTON (68180-433-02) / 3 mL in 1 BO... bromfenac sodium Lupin Pharmaceuticals, Inc. 2024-01-08
75907-0093-03 1 BOTTLE, DROPPER in 1 CARTON (75907-093-03) / 3 mL in 1 BO... bromfenac ophthalmic solution Dr. Reddy's Laboratories Inc. 2024-07-15
82260-0602-03 1 BOTTLE, DROPPER in 1 CARTON (82260-602-03) / 3 mL in 1 BO... bromfenac ophthalmic solution Bausch & Lomb Americas Inc. 2024-01-08
Observed labelers: Bausch & Lomb Incorporated (3) · Apotex Corp. (2) · Alembic Pharmaceuticals Inc. (1) · Alembic Pharmaceuticals Limited (1) · Amneal Pharmaceuticals NY LLC (1) · Bausch & Lomb Americas Inc. (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.